lanreotide acetate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
MYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe AUST R: 371879Active ingredients:
lanreotide acetate
Dosage form: Injection, solution
Sponsor: Amdipharm Mercury Australia Pty Ltd
Phone: 1800 627 680
|
From 20 Jun 2025 to 19 Jul 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: An alternative generic product is available.
|
MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe AUST R: 371881Active ingredients:
lanreotide acetate
Dosage form: Injection, solution
Sponsor: Amdipharm Mercury Australia Pty Ltd
Phone: 1800 627 680
|
From 29 Nov 2024 to 31 Dec 2025
|
Shortage status: Current
Availability: Unavailable
Reason: Transport / Logistic issues / Storage capacity issues
Management action: An alternative generic product is available.
|